{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:49:55Z","timestamp":1792817395689,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["P50CA275741"],"award-info":[{"award-number":["P50CA275741"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RP-19-181-01-RMC"],"award-info":[{"award-number":["RP-19-181-01-RMC"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["HT9425-24-1-0070"],"award-info":[{"award-number":["HT9425-24-1-0070"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100027153","name":"Portland Community Fund","doi-asserted-by":"publisher","award":["R01CA235741"],"award-info":[{"award-number":["R01CA235741"]}],"id":[{"id":"10.13039\/100027153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA242986"],"award-info":[{"award-number":["R35CA242986"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ccell.2025.02.027","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T15:29:32Z","timestamp":1742484572000},"page":"841-855.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Small-molecule RNA therapeutics to target prostate cancer"],"prefix":"10.1016","volume":"43","author":[{"given":"Duygu","family":"Kuzuoglu-Ozturk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao G.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingru","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Figueredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishvak","family":"Subramanyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Bonitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna","family":"Dabrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Oses-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma L.","family":"Burlingame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Worland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-5865","authenticated-orcid":false,"given":"Davide","family":"Ruggero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2025.02.027_bib1","series-title":"Cancer Facts & Figures","year":"2024"},{"key":"10.1016\/j.ccell.2025.02.027_bib2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41576-020-0258-4","article-title":"mRNAs, proteins and the emerging principles of gene expression control","volume":"21","author":"Buccitelli","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ccell.2025.02.027_bib3","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109823","article-title":"Protein synthesis control in cancer: selectivity and therapeutic targeting","volume":"41","author":"Kovalski","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2025.02.027_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s13059-014-0476-1","article-title":"Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation","volume":"15","author":"Rubio","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2025.02.027_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature13485","article-title":"RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer","volume":"513","author":"Wolfe","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.02.027_bib6","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3389\/fonc.2019.01311","article-title":"Targeting of the eukaryotic translation initiation factor 4A against breast cancer stemness","volume":"9","author":"Sridharan","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccell.2025.02.027_bib7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bbcan.2017.09.006","article-title":"Targeting RNA helicases in cancer: The translation trap","volume":"1868","author":"van Voss","year":"2017","journal-title":"Biochimica Et Biophysica Acta Bba - Rev Cancer"},{"key":"10.1016\/j.ccell.2025.02.027_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/B978-0-12-396546-2.00020-6","article-title":"Inhibitors of translation targeting eukaryotic translation initiation factor 4A","volume":"511","author":"Cencic","year":"2012","journal-title":"Meth. Enzymol."},{"key":"10.1016\/j.ccell.2025.02.027_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature17978","article-title":"Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor","volume":"534","author":"Iwasaki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.02.027_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/1535-7163.MCT-19-0973","article-title":"Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A","volume":"20","author":"Thompson","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ccell.2025.02.027_bib11","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1021\/acs.jmedchem.0c00182","article-title":"Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase","volume":"63","author":"Ernst","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ccell.2025.02.027_bib12","article-title":"Hypoxic radioresistance: can ROS be the key to overcome it?","volume":"11","author":"Wang","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ccell.2025.02.027_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar2036","article-title":"Development of a stress response therapy targeting aggressive prostate cancer","volume":"10","author":"Nguyen","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2025.02.027_bib14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.eururo.2018.02.019","article-title":"Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer","volume":"73","author":"Hao","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ccell.2025.02.027_bib15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.cell.2016.02.058","article-title":"Snapshot: timescales in cell biology","volume":"164","author":"Shamir","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.02.027_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1168978","article-title":"Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling","volume":"324","author":"Ingolia","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.02.027_bib17","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1158\/0008-5472.CAN-15-1654","article-title":"Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations","volume":"75","author":"Dogruluk","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.02.027_bib18","doi-asserted-by":"crossref","first-page":"e150335","DOI":"10.1172\/JCI150335","article-title":"Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma","volume":"131","author":"Jin","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2025.02.027_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2018.01.021","article-title":"Systematic functional annotation of somatic mutations in cancer","volume":"33","author":"Ng","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.02.027_bib20","first-page":"TPS178","article-title":"A phase III trial of capivasertib and abiraterone versus placebo and abiraterone in patients with de novo metastatic hormone-sensitive prostate cancer characterized by PTEN deficiency (CAPItello-281)","volume":"39","author":"Fizazi","year":"2021","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.ccell.2025.02.027_bib21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.02.027_bib22","first-page":"157","article-title":"Androgen receptor genomic regulation","volume":"2","author":"Jin","year":"2013","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.ccell.2025.02.027_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","article-title":"Development of a second-generation antiandrogen for treatment of advanced prostate cancer","volume":"324","author":"Tran","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.02.027_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1756287213490054","article-title":"Evidence for the efficacy of enzalutamide in postchemotherapy metastatic castrate-resistant prostate cancer","volume":"5","author":"Saad","year":"2013","journal-title":"Ther. Adv. Urol."},{"key":"10.1016\/j.ccell.2025.02.027_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clgc.2018.07.017","article-title":"Clinical development of darolutamide: A novel androgen receptor antagonist for the treatment of prostate cancer","volume":"16","author":"Fizazi","year":"2018","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.ccell.2025.02.027_bib26","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJMoa2001342","article-title":"Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide","volume":"383","author":"Fizazi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.02.027_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep12007","article-title":"Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies","volume":"5","author":"Moilanen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2025.02.027_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nmeth.4057","article-title":"DMS-MaPseq for genome-wide or targeted RNA structure probing in vivo","volume":"14","author":"Zubradt","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.02.027_bib29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.molcel.2018.11.026","article-title":"The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA","volume":"73","author":"Iwasaki","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2025.02.027_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.02.027_bib31","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2025.02.027_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2025.02.027_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-3-030-51652-9_17","article-title":"HIF-1\u03b1 Metabolic Pathways in Human Cancer","volume":"1280","author":"Elzakra","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ccell.2025.02.027_bib34","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.biocel.2010.08.009","article-title":"Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect","volume":"43","author":"Weljie","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ccell.2025.02.027_bib35","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrc2540","article-title":"The impact of O2 availability on human cancer","volume":"8","author":"Bertout","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.02.027_bib36","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.02.027_bib37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41585-020-0298-8","article-title":"Cellular rewiring in lethal prostate cancer: the architect of drug resistance","volume":"17","author":"Carceles-Cordon","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ccell.2025.02.027_bib38","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s43018-023-00594-z","article-title":"The Akt\/mTOR and MNK\/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells","volume":"4","author":"Brina","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ccell.2025.02.027_bib39","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1158\/2159-8290.CD-23-0306","article-title":"Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer","volume":"13","author":"Santasusagna","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.02.027_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw4993","article-title":"The androgen receptor regulates a druggable translational regulon in advanced prostate cancer","volume":"11","author":"Liu","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2025.02.027_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2010.01.021","article-title":"Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E","volume":"17","author":"Hsieh","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.02.027_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1474","article-title":"Genetic variants in mRNA untranslated regions","volume":"9","author":"Steri","year":"2018","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.ccell.2025.02.027_bib43","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1038\/s41467-021-24445-6","article-title":"Multiplexed functional genomic analysis of 5\u2019 untranslated region mutations across the spectrum of prostate cancer","volume":"12","author":"Lim","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.02.027_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41588-021-00830-1","article-title":"Functional and structural basis of extreme conservation in vertebrate 5\u2019 untranslated regions","volume":"53","author":"Byeon","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2025.02.027_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720906777","article-title":"Long Noncoding RNA PCED1B-AS1 Promotes the Warburg Effect and Tumorigenesis by Upregulating HIF-1\u03b1 in Glioblastoma","volume":"29","author":"Yao","year":"2020","journal-title":"Cell Transplant."},{"key":"10.1016\/j.ccell.2025.02.027_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2016.02.022","article-title":"RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1\u03b1 mRNA is translated","volume":"376","author":"Tanabe","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ccell.2025.02.027_bib47","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1091\/mbc.02-02-0017","article-title":"Hypoxia-inducible Factor-1\u03b1 mRNA Contains an Internal Ribosome Entry Site That Allows Efficient Translation during Normoxia and Hypoxia","volume":"13","author":"Lang","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ccell.2025.02.027_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.580176","article-title":"Long Noncoding RNA MIR210HG Promotes the Warburg Effect and Tumor Growth by Enhancing HIF-1\u03b1 Translation in Triple-Negative Breast Cancer","volume":"10","author":"Du","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccell.2025.02.027_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005223","article-title":"Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol","volume":"4","author":"Cencic","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2025.02.027_bib50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/1541-7786.MCR-06-0226","article-title":"Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells","volume":"5","author":"Horii","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ccell.2025.02.027_bib51","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1158\/0008-5472.CAN-05-1341","article-title":"Hypoxia increases androgen receptor activity in prostate cancer cells","volume":"66","author":"Park","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.02.027_bib52","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1038\/s41467-018-07411-7","article-title":"Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen\/AR-targeted therapy","volume":"9","author":"Geng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.02.027_bib53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12885-020-06890-6","article-title":"Independence of HIF1a and androgen signaling pathways in prostate cancer","volume":"20","author":"Tran","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ccell.2025.02.027_bib54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymeth.2017.05.028","article-title":"Transcriptome-wide measurement of translation by ribosome profiling","volume":"126","author":"McGlincy","year":"2017","journal-title":"Methods"},{"key":"10.1016\/j.ccell.2025.02.027_bib55","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.02.027_bib56","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gr.209601.116","article-title":"UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy","volume":"27","author":"Smith","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.ccell.2025.02.027_bib57","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41556-023-01141-9","article-title":"An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus","volume":"25","author":"Navickas","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccell.2025.02.027_bib58","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/bioinformatics\/btp250","article-title":"VARNA: Interactive drawing and editing of the RNA secondary structure","volume":"25","author":"Darty","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2025.02.027_bib59","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2025.02.027_bib60","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2016","journal-title":"bioRxiv"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:05:41Z","timestamp":1762549541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610825000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1535610825000790"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2025.02.027","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small-molecule RNA therapeutics to target prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}